Central Line Catheterization With Flexible Tip Straight Guidewire in Small Children
Central Line Insertion Technique in Small Infants Using Flexible Tip Straight Guidewire and J-tip Guidewire: a Randomized Controlled Trials
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of, 03080
- Seoul National University Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- surgery under general anesthesia
- require central venous catheterization
Exclusion Criteria:
- central vein anomaly
- hematoma in central vein
- catheterization site infection
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Flexible tip straight guidewire
|
Use a flexible tip straight guidewire for ultrasound-guided central venous catheterization
|
|
Experimental: J-tip guidewire
|
Use a J tip straight guidewire for ultrasound-guided central venous catheterization
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
First successful central venous catheterization rate
Time Frame: Interval between skin penetration of the needle and installation of the indwelling catheter, an expected average of 3 minutes
|
Interval between skin penetration of the needle and installation of the indwelling catheter, an expected average of 3 minutes
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Time to first puncture of central vein
Time Frame: Interval between skin penetration of the needle and flashback of blood, an expected average of 30 seconds
|
Interval between skin penetration of the needle and flashback of blood, an expected average of 30 seconds
|
|
Time to guide wire insertion
Time Frame: Interval between skin penetration and removal of the needle after guide wire insertion, an expected average of 90 seconds
|
Interval between skin penetration and removal of the needle after guide wire insertion, an expected average of 90 seconds
|
|
Total time to central venous catheterization
Time Frame: Interval between skin penetration of the needle and installation of the indwelling catheter, an expected average of 3 minutes
|
Interval between skin penetration of the needle and installation of the indwelling catheter, an expected average of 3 minutes
|
|
Number of central vein puncture trial
Time Frame: up to 5 times, an expected average observation time of 30 seconds
|
up to 5 times, an expected average observation time of 30 seconds
|
|
Number of guide wire insertion trial
Time Frame: up to 5 times, an expected average observation time of 90 seconds
|
up to 5 times, an expected average observation time of 90 seconds
|
|
First successful central vein puncture rate
Time Frame: Interval between skin penetration of the needle or angiocatheter and flashback of blood, an expected average of 30 seconds
|
Interval between skin penetration of the needle or angiocatheter and flashback of blood, an expected average of 30 seconds
|
|
First successful guide wire insertion rate
Time Frame: Interval between skin penetration and removal of the needle after guide wire insertion, an expected average of 90 seconds
|
Interval between skin penetration and removal of the needle after guide wire insertion, an expected average of 90 seconds
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Jin-Tae Kim, Professor, Seoul National University Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- H-1803-150-935
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.